| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 5.99M | — |
| Operating expense | — | — |
| Net income | -18.93M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CLLS returned +19.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -29.6% |
| 1 year | +19.5% |
| 5 years | -76.3% |
| 10 years | -87.2% |
| All-time high | $42.90 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CLLS would be worth today ›No. Cellectis S.A. has not paid a dividend in the past 12 months.
Cellectis S.A. stock trades on NASDAQ under the ticker symbol CLLS.
Cellectis S.A. is part of the Healthcare sector.
Cellectis S.A. has a market cap of 342.89M USD, based on the latest quote.